The effects of recombinant human growth hormone therapy on thyroid function in pediatric patients with growth hormone deficiency

BACKGROUND: Recombinant human growth hormone (rhGH) was approved for the therapy of pediatric patients with growth hormone deficiency (GHD) by the Food and Drug Administration (FDA) of the United States in 1985. This study aims to evaluate the effects of rhGH therapy on thyroid function in pediatric...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Qian, Zheng, Dong, Liang, Yan, Hou, Ling, Ying, Yan-Qin, Luo, Xiao-Ping, Wu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107847/
https://www.ncbi.nlm.nih.gov/pubmed/34012834
http://dx.doi.org/10.21037/tp-20-401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107847/
https://www.ncbi.nlm.nih.gov/pubmed/34012834
http://dx.doi.org/10.21037/tp-20-401

Ejemplares similares